tiprankstipranks
Eton Pharmaceuticals Inc (ETON)
NASDAQ:ETON
US Market
ETON
Eton Pharmaceuticals
RESEARCH TOOLSreports

Eton Pharmaceuticals (ETON) Financial Statements

Compare
544 Followers

Eton Pharmaceuticals Financial Overview

Eton Pharmaceuticals's market cap is currently $639.82M. The company's EPS TTM is $0.05; its P/E ratio is 76.71; Eton Pharmaceuticals is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is $0.11. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 79.95M$ 39.01M$ 31.64M$ 21.25M$ 21.83M
Gross Profit$ 42.74M$ 23.41M$ 21.06M$ 14.32M$ 19.21M
Operating Income$ 72.00K$ -2.60M$ -1.19M$ -8.26M$ -1.50M
EBITDA$ 4.12M$ -1.45M$ -291.00K$ -6.49M$ -1.03M
Net Income$ -4.60M$ -3.82M$ -936.00K$ -9.02M$ -1.96M
Balance Sheet
Cash & Short-Term Investments$ 25.94M$ 14.94M$ 21.39M$ 16.30M$ 14.41M
Total Assets$ 92.11M$ 76.12M$ 31.74M$ 25.03M$ 27.46M
Total Debt$ 9.25M$ 29.92M$ 5.40M$ 6.52M$ 6.70M
Net Debt$ -16.69M$ 14.98M$ -15.99M$ -9.78M$ -7.71M
Total Liabilities$ 65.96M$ 51.70M$ 16.26M$ 11.95M$ 9.84M
Stockholders' Equity$ 26.15M$ 24.43M$ 15.48M$ 13.08M$ 17.63M
Cash Flow
Free Cash Flow$ 10.19M$ 943.00K$ 6.04M$ 2.03M$ -7.98M
Operating Cash Flow$ 10.52M$ 969.00K$ 6.82M$ 4.82M$ -4.72M
Investing Cash Flow$ -333.00K$ -40.01M$ -775.00K$ -2.79M$ -2.56M
Financing Cash Flow$ 815.00K$ 32.59M$ -957.00K$ -134.00K$ 391.00K
Currency in USD

Eton Pharmaceuticals Earnings and Revenue History

Income Statement >

Eton Pharmaceuticals Debt to Assets

Balance Sheet >

Eton Pharmaceuticals Cash Flow

Cash Flow >

Eton Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >